相关实验视频

Updated: Jul 18, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

解读经典霍奇金淋巴瘤的遗传复杂性:见解和有效的策略

Chaeyoung Lee¹, Yeeun An¹

¹Department of Bioinformatics and Life Science, Soongsil University, Seoul 06978, Korea.

Current genomics

|September 26, 2024

概括

由于罕见的瘤细胞,对经典霍奇金淋巴瘤 (cHL) 的遗传洞察力有限. 先进的技术揭示了HRS细胞中的瘤基因驱动因素,并建议了cHL精密瘤学的未来战略.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
癌症生物学癌症生物学

背景情况:

理解古典霍奇金淋巴瘤 (cHL) 遗传学是具有挑战性的,因为罕见的恶性霍奇金和里德-斯特恩伯格 (HRS) 细胞在复杂的微环境中.
之前的研究对导致cHL易感性的特定遗传因素的洞察力有限.

研究的目的:

利用最近的技术进步,阐明cHL中的遗传异常,核酸变异和向基因.
突出瘤基因组学在HRS细胞存活和增殖中的作用,以及它们与瘤微环境的相互作用.
确定在cHL中推进精确瘤学的关键策略.

主要方法:

对HRS细胞中的瘤基因组进行分析,以确定过度活跃的信号通路 (例如NF-kB).
整合全基因组关联研究 (GWAS) 和表达量化特征位置 (eQTL) 分析.
探索遗传异质性,eQTL局部化和单细胞分析.

主要成果:

瘤基因组数据显示,HRS细胞通过过度活跃的信号通路,特别是NF-kB,促进它们的生存和繁殖.
HRS细胞与微环境细胞相互作用,例如CD4+ T细胞.
在更广泛的癌症背景下,GWAS和eQTL研究提供了对更广泛的癌症情境中的易感性基因的一般,但不那么具体的理解.

结论:

先进的基因组分析对于了解cHL病原体至关重要.
未来的研究应该集中在遗传异质性 (按性别和亚型),eQTL局部化和单细胞方法上,以解开cHL的遗传复杂性.
这些策略对于开发CHL精密瘤治疗方法至关重要.

关键词:

霍奇金淋巴瘤是一种霍奇金淋巴瘤.在 NF-kBB 中.表达方式定量特征位置位置遗传病因学遗传病因学遗传异质性的遗传异质性遗传损伤是一种遗传损伤.全基因组关联研究研究.霍奇金和里德-斯特恩伯格细胞

更多相关视频

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...